Skip to main content
. Author manuscript; available in PMC: 2013 Aug 13.
Published in final edited form as: Lancet Infect Dis. 2012 Feb;12(2):157–166. doi: 10.1016/S1473-3099(11)70244-4

Table 3.

The effect of surgical resection on clinical outcomes from cohort studies comparing drug resistant tuberculosis patients undergoing combination surgical resection and medical treatment vs. medical treatment alone

Author Country Years Cohort Size ( % having surgery) MDRa/ XDRb Analysis Overall treatment success Effect of Surgical Resection on Clinical Outcomes
Univariate HRc (95% CI) Multivariate HRc (95% CI)
Jeon 200947 Korea 2001–2005 176 (9%) XDR Predictors of poor outcomed 18% 0.08 (.02–0.28) 0.18 (0.04–0.78)
Kwon 200848 Korea 1995–2004 155 (23%) MDR
XDR
Predictors of favorable outcomee 66% - 11.35 (3.02, 42.74)
Keshavjee 200858 Russia 2000–2004 608 (9%) MDR
XDR
Predictors of favorable outcomee 66% 1.24 (0.69–2.26) - f
KIm 200849 Korea 2000–2002 1407 (4%) MDR
XDR
Predictors of favorable outcomee 45% 2.72 (1.56, 4.73) 3.87 (1.69, 8.88)
Kim 200750 Korea 1996–2005 211 (30%) MDR
XDR
Predictors of poor outcomed 63% 1.36 (0.70, 2.65) - f
Torun 200759 Turkey 1992–2004 252 (26%) MDR Predictors of favorable outcomee 77% 1.7 (0.8–3.5) 1.5 (0.64, 3.46)
Leimane 200555 Latvia 2000 204 (9%) MDR Predictors of poor outcomed 66% 0.3 (0.1–1.2) -f
Chan 200453 USA 1984–1998 205 (63%) MDR Predictors of initial favorable responseg 75% 4.63 (1.89, 11.37) 4.23 (1.28, 13.93)
a

Multidrug Resistant

b

Extensively drug resistant

c

Hazard Ratio

d

Treatment failure, death during treatment, or default72,74

e

Cure or completed treatment72,74

f

Non significant; no value given

g

Defined by at least 3 consecutive negative sputum cultures over at least 3 months while on treatment